OBJECTIVE To evaluate the effects of a levonorgestrel-releasing intrauterine device in the treatment of adenomyosis associated with heavy menstrual bleeding. METHODS The retrospective study was conducted at a tertiary referral hospital in Izmir, Turkey, and comprised data on adenomyosis patients who were implanted with a levonorgestrel-releasing intrauterine device for heavy menstrual bleedin...

The Dalkon Shield was an intrauterine contraceptive device (IUD) that women used in the early 1970s and 1980s. Produced by the A.H. Robins Company in the US, the Dalkon Shield was a contraceptive device placed directly into a woman?s uterus [3] that was supposed to prevent pregnancy [4]. In the 1980s, researchers discovered that the Dalkon Shield caused an array of severe injuries, including pe...

A number of complications are reported with the use of intrauterine contraceptive devices. These may pursue asymptomatic course or present as an acute abdomen after migration into peritoneal cavity. The authors here are reporting an abdominal wall swelling caused by transuterine migration of a copper intrauterine contraceptive device in a 28-year-old female. An open approach was used, and impac...

BACKGROUND Among adolescent pregnancies, 75% are unintended. Greater use of highly-effective contraception can reduce unintended pregnancy. Although multiple studies discuss adolescent contraceptive use, there is no consensus regarding the use of long-acting reversible contraception as a first-line contraception option. OBJECTIVE We performed a systematic review of the medical literature to a...

Background: Intrauterine Device (IUD) is an effective and long term method of contraception that can be used without continued effort by the user to prevent pregnancy perfectly. Pain during IUD insertion is one of the obstacles to properly using the device. Thus, using different methods of analgesia and anesthesia to alleviate this pain has been studied by many researchers. This review article ...

Preliminary acceptability and reliability tests of the Dalkon Shield were done in 377 women over 17 months, amounting to 3,028 months of use. There was a 98% follow-up. The pregnancy rate of 4.7 and expulsion rate of 6.3 do not meet the claims described in initial trials by the developers of the device. Nevertheless, the Dalkon Shield seems to be an advance in intrauterine contraception since i...